UroGen Pharma Ltd. (URGN)
18.59
+0.11
(+0.60%)
USD |
NASDAQ |
Mar 19, 16:00
18.84
+0.25
(+1.34%)
After-Hours: 05:02
UroGen Pharma Total Liabilities (Quarterly) : 305.93M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| RadNet, Inc. | 2.652B |
| Zymeworks, Inc. | 78.03M |
| Xeris Biopharma Holdings, Inc. | 379.25M |
| Caribou Biosciences, Inc. | 57.46M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.46M |
| Shareholders Equity (Quarterly) | -105.47M |
| Debt to Equity Ratio | -1.233 |
| Current Ratio | 4.008 |
| Net Debt Paydown Yield | -0.13% |